These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18287870)

  • 1. From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures.
    Boruban MC; Altundag K; Kilic GS; Blankstein J
    Eur J Cancer Prev; 2008 Apr; 17(2):133-8. PubMed ID: 18287870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
    Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D; Horn LC
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia].
    Francz M
    Magy Onkol; 2008 Mar; 52(1):35-40. PubMed ID: 18403295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal pathology of the endometrium.
    Deligdisch L
    Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of immunoreactivity and genetic mutation in eosinophilic and ciliated metaplastic changes of endometrial glandular and stromal breakdown: cytodiagnostic implications.
    Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
    Ann Diagn Pathol; 2009 Apr; 13(2):89-95. PubMed ID: 19302956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibitors and the endometrium.
    Cohen I
    Maturitas; 2008 Apr; 59(4):285-92. PubMed ID: 18448280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option.
    Gadducci A; Spirito N; Baroni E; Tana R; Genazzani AR
    Gynecol Endocrinol; 2009 Oct; 25(10):683-91. PubMed ID: 19562604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
    Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
    Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
    McKenney JK; Longacre TA
    Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
    Bersteĭn LM; Chernobrovkina AE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Maksimov SIa; Chepik OF; Gershfel'd ED
    Vopr Onkol; 2003; 49(1):55-9. PubMed ID: 12715371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC; Meinel A; Handzel R; Einenkel J
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
    Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.